| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $84.6M | +15.2% |
| Cost of Revenue | $57.8M | +4.6% |
| R&D Expense | $48.9M | -24.5% |
| SG&A Expense | $46.2M | -7.1% |
| Operating Income | -$68.3M | +37.9% |
| Interest Expense | $24K | -78.2% |
| Pre-tax Income | -$81.3M | +24.9% |
| Income Tax | $18K | -78.3% |
| Net Income | -$81.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $91.4M | +60.4% |
| Short-term Investments | $93.6M | +63.6% |
| Accounts Receivable | $8.1M | -54.1% |
| Current Assets | $203.0M | +38.3% |
| Total Assets | $270.3M | +20.1% |
| Current Liabilities | $31.1M | -34.1% |
| Total Liabilities | $67.3M | -29.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.1M | +19.7% |
| Capital Expenditures | $1.6M | -85.3% |
| Investing Cash Flow | -$35.1M | -367.7% |
| Financing Cash Flow | $114.7M | +939.5% |
| Free Cash Flow | -$46.8M | +30.4% |
| +24.9% |
| EPS (Basic) | -$1.37 | +39.1% |
| EPS (Diluted) | -$1.37 | +39.1% |
| Stockholders' Equity |
| $203.0M |
| +56.8% |